nodes	percent_of_prediction	percent_of_DWPC	metapath
Dopamine—SLC22A3—Lamivudine—acquired immunodeficiency syndrome	0.0564	0.0673	CbGbCtD
Dopamine—SLC22A1—Indinavir—acquired immunodeficiency syndrome	0.0445	0.0531	CbGbCtD
Dopamine—SLC22A1—Nelfinavir—acquired immunodeficiency syndrome	0.0432	0.0516	CbGbCtD
Dopamine—SLC22A2—Zidovudine—acquired immunodeficiency syndrome	0.0432	0.0515	CbGbCtD
Dopamine—SLC22A1—Saquinavir—acquired immunodeficiency syndrome	0.0391	0.0466	CbGbCtD
Dopamine—SLC22A2—Lamivudine—acquired immunodeficiency syndrome	0.0334	0.0398	CbGbCtD
Dopamine—SLC22A1—Lamivudine—acquired immunodeficiency syndrome	0.029	0.0346	CbGbCtD
Dopamine—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.023	0.0275	CbGbCtD
Dopamine—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.0217	0.0258	CbGbCtD
Dopamine—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.0213	0.0254	CbGbCtD
Dopamine—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.02	0.0238	CbGbCtD
Dopamine—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.02	0.0238	CbGbCtD
Dopamine—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.0196	0.0234	CbGbCtD
Dopamine—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.0196	0.0234	CbGbCtD
Dopamine—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0192	0.0228	CbGbCtD
Dopamine—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.0181	0.0216	CbGbCtD
Dopamine—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.018	0.0215	CbGbCtD
Dopamine—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.018	0.0215	CbGbCtD
Dopamine—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0175	0.0209	CbGbCtD
Dopamine—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.0169	0.0202	CbGbCtD
Dopamine—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0165	0.0196	CbGbCtD
Dopamine—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0165	0.0196	CbGbCtD
Dopamine—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.0164	0.0196	CbGbCtD
Dopamine—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0163	0.0194	CbGbCtD
Dopamine—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0163	0.0194	CbGbCtD
Dopamine—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0152	0.0181	CbGbCtD
Dopamine—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0149	0.0178	CbGbCtD
Dopamine—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0149	0.0178	CbGbCtD
Dopamine—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.0149	0.0177	CbGbCtD
Dopamine—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.0149	0.0177	CbGbCtD
Dopamine—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.0142	0.017	CbGbCtD
Dopamine—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.0141	0.0168	CbGbCtD
Dopamine—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.0137	0.0163	CbGbCtD
Dopamine—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.0137	0.0163	CbGbCtD
Dopamine—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0129	0.0153	CbGbCtD
Dopamine—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0125	0.0149	CbGbCtD
Dopamine—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.0123	0.0147	CbGbCtD
Dopamine—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.0123	0.0147	CbGbCtD
Dopamine—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.0118	0.0141	CbGbCtD
Dopamine—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.0113	0.0135	CbGbCtD
Dopamine—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.0113	0.0135	CbGbCtD
Dopamine—DBH—nerve—acquired immunodeficiency syndrome	0.0045	0.05	CbGeAlD
Dopamine—DRD1—nerve—acquired immunodeficiency syndrome	0.00264	0.0294	CbGeAlD
Dopamine—Necrosis—Nevirapine—acquired immunodeficiency syndrome	0.00235	0.0605	CcSEcCtD
Dopamine—SLC6A3—nerve—acquired immunodeficiency syndrome	0.00212	0.0236	CbGeAlD
Dopamine—MAOB—nerve—acquired immunodeficiency syndrome	0.00185	0.0206	CbGeAlD
Dopamine—COMT—blood plasma—acquired immunodeficiency syndrome	0.0018	0.02	CbGeAlD
Dopamine—Necrosis—Efavirenz—acquired immunodeficiency syndrome	0.00174	0.0446	CcSEcCtD
Dopamine—SLC6A2—nerve—acquired immunodeficiency syndrome	0.00171	0.019	CbGeAlD
Dopamine—Necrosis—Delavirdine—acquired immunodeficiency syndrome	0.00166	0.0427	CcSEcCtD
Dopamine—HTR7—nerve—acquired immunodeficiency syndrome	0.00165	0.0184	CbGeAlD
Dopamine—Cyanosis—Saquinavir—acquired immunodeficiency syndrome	0.00164	0.0421	CcSEcCtD
Dopamine—Menorrhagia—Ritonavir—acquired immunodeficiency syndrome	0.00163	0.0419	CcSEcCtD
Dopamine—MAOA—nerve—acquired immunodeficiency syndrome	0.00158	0.0175	CbGeAlD
Dopamine—DRD2—nerve—acquired immunodeficiency syndrome	0.00156	0.0174	CbGeAlD
Dopamine—SLC6A4—blood plasma—acquired immunodeficiency syndrome	0.00147	0.0164	CbGeAlD
Dopamine—HTR7—endothelium—acquired immunodeficiency syndrome	0.00141	0.0156	CbGeAlD
Dopamine—MAOB—blood plasma—acquired immunodeficiency syndrome	0.0014	0.0156	CbGeAlD
Dopamine—DBH—digestive system—acquired immunodeficiency syndrome	0.00131	0.0145	CbGeAlD
Dopamine—HTR1A—blood plasma—acquired immunodeficiency syndrome	0.00131	0.0145	CbGeAlD
Dopamine—HTR7—blood plasma—acquired immunodeficiency syndrome	0.00125	0.0139	CbGeAlD
Dopamine—DBH—blood—acquired immunodeficiency syndrome	0.00125	0.0139	CbGeAlD
Dopamine—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.00122	0.0136	CbGeAlD
Dopamine—DBH—bone marrow—acquired immunodeficiency syndrome	0.00121	0.0134	CbGeAlD
Dopamine—MAOA—blood plasma—acquired immunodeficiency syndrome	0.00119	0.0133	CbGeAlD
Dopamine—DRD5—lymphoid tissue—acquired immunodeficiency syndrome	0.00102	0.0113	CbGeAlD
Dopamine—DBH—nervous system—acquired immunodeficiency syndrome	0.00101	0.0112	CbGeAlD
Dopamine—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.000996	0.0111	CbGeAlD
Dopamine—DBH—central nervous system—acquired immunodeficiency syndrome	0.000974	0.0108	CbGeAlD
Dopamine—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.000945	0.0105	CbGeAlD
Dopamine—DRD4—brain—acquired immunodeficiency syndrome	0.000903	0.01	CbGeAlD
Dopamine—Angina pectoris—Indinavir—acquired immunodeficiency syndrome	0.000882	0.0226	CcSEcCtD
Dopamine—COMT—skin of body—acquired immunodeficiency syndrome	0.000865	0.00961	CbGeAlD
Dopamine—SLC22A2—digestive system—acquired immunodeficiency syndrome	0.000861	0.00957	CbGeAlD
Dopamine—DRD3—nervous system—acquired immunodeficiency syndrome	0.00083	0.00922	CbGeAlD
Dopamine—DRD3—central nervous system—acquired immunodeficiency syndrome	0.000799	0.00888	CbGeAlD
Dopamine—DRD5—nervous system—acquired immunodeficiency syndrome	0.000778	0.00864	CbGeAlD
Dopamine—DBH—brain—acquired immunodeficiency syndrome	0.000773	0.00859	CbGeAlD
Dopamine—DRD5—central nervous system—acquired immunodeficiency syndrome	0.000749	0.00832	CbGeAlD
Dopamine—DBH—lymph node—acquired immunodeficiency syndrome	0.000747	0.0083	CbGeAlD
Dopamine—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000709	0.00788	CbGeAlD
Dopamine—COMT—digestive system—acquired immunodeficiency syndrome	0.000692	0.00769	CbGeAlD
Dopamine—Bradycardia—Delavirdine—acquired immunodeficiency syndrome	0.000667	0.0171	CcSEcCtD
Dopamine—Anxiety—Nelfinavir—acquired immunodeficiency syndrome	0.000664	0.0171	CcSEcCtD
Dopamine—Anxiety—Stavudine—acquired immunodeficiency syndrome	0.000662	0.017	CcSEcCtD
Dopamine—COMT—blood—acquired immunodeficiency syndrome	0.000659	0.00732	CbGeAlD
Dopamine—MAOA—retina—acquired immunodeficiency syndrome	0.000654	0.00727	CbGeAlD
Dopamine—Anxiety—Abacavir—acquired immunodeficiency syndrome	0.000652	0.0167	CcSEcCtD
Dopamine—DRD2—retina—acquired immunodeficiency syndrome	0.000647	0.00719	CbGeAlD
Dopamine—COMT—bone marrow—acquired immunodeficiency syndrome	0.000638	0.00709	CbGeAlD
Dopamine—COMT—spinal cord—acquired immunodeficiency syndrome	0.000635	0.00705	CbGeAlD
Dopamine—DRD3—brain—acquired immunodeficiency syndrome	0.000634	0.00705	CbGeAlD
Dopamine—COMT—vagina—acquired immunodeficiency syndrome	0.000611	0.00679	CbGeAlD
Dopamine—SLC22A5—retina—acquired immunodeficiency syndrome	0.000602	0.00669	CbGeAlD
Dopamine—DRD5—brain—acquired immunodeficiency syndrome	0.000595	0.00661	CbGeAlD
Dopamine—DRD1—nervous system—acquired immunodeficiency syndrome	0.000594	0.00661	CbGeAlD
Dopamine—SLC22A1—blood—acquired immunodeficiency syndrome	0.00058	0.00644	CbGeAlD
Dopamine—COMT—lung—acquired immunodeficiency syndrome	0.000578	0.00642	CbGeAlD
Dopamine—Anxiety—Zidovudine—acquired immunodeficiency syndrome	0.000575	0.0148	CcSEcCtD
Dopamine—DRD1—central nervous system—acquired immunodeficiency syndrome	0.000572	0.00636	CbGeAlD
Dopamine—Dyspnoea—Nelfinavir—acquired immunodeficiency syndrome	0.000569	0.0146	CcSEcCtD
Dopamine—SLC6A3—spinal cord—acquired immunodeficiency syndrome	0.000567	0.0063	CbGeAlD
Dopamine—SLC6A4—digestive system—acquired immunodeficiency syndrome	0.000566	0.00629	CbGeAlD
Dopamine—Dyspnoea—Abacavir—acquired immunodeficiency syndrome	0.000559	0.0144	CcSEcCtD
Dopamine—Palpitations—Indinavir—acquired immunodeficiency syndrome	0.000557	0.0143	CcSEcCtD
Dopamine—SLC6A4—blood—acquired immunodeficiency syndrome	0.000539	0.00599	CbGeAlD
Dopamine—MAOB—digestive system—acquired immunodeficiency syndrome	0.000538	0.00598	CbGeAlD
Dopamine—SLC22A1—vagina—acquired immunodeficiency syndrome	0.000537	0.00597	CbGeAlD
Dopamine—Anxiety—Indinavir—acquired immunodeficiency syndrome	0.000535	0.0137	CcSEcCtD
Dopamine—COMT—nervous system—acquired immunodeficiency syndrome	0.000535	0.00594	CbGeAlD
Dopamine—SLC22A5—skin of body—acquired immunodeficiency syndrome	0.000529	0.00587	CbGeAlD
Dopamine—Palpitations—Efavirenz—acquired immunodeficiency syndrome	0.000527	0.0135	CcSEcCtD
Dopamine—SLC6A4—spinal cord—acquired immunodeficiency syndrome	0.000519	0.00577	CbGeAlD
Dopamine—SLC6A3—lung—acquired immunodeficiency syndrome	0.000516	0.00573	CbGeAlD
Dopamine—COMT—central nervous system—acquired immunodeficiency syndrome	0.000515	0.00572	CbGeAlD
Dopamine—Hypertension—Efavirenz—acquired immunodeficiency syndrome	0.000514	0.0132	CcSEcCtD
Dopamine—SLC22A3—vagina—acquired immunodeficiency syndrome	0.000513	0.00571	CbGeAlD
Dopamine—MAOB—blood—acquired immunodeficiency syndrome	0.000513	0.0057	CbGeAlD
Dopamine—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000512	0.0131	CcSEcCtD
Dopamine—Anxiety—Efavirenz—acquired immunodeficiency syndrome	0.000506	0.013	CcSEcCtD
Dopamine—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000504	0.0129	CcSEcCtD
Dopamine—Palpitations—Delavirdine—acquired immunodeficiency syndrome	0.000504	0.0129	CcSEcCtD
Dopamine—MAOB—spinal cord—acquired immunodeficiency syndrome	0.000494	0.00549	CbGeAlD
Dopamine—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.000493	0.0127	CcSEcCtD
Dopamine—Hypertension—Delavirdine—acquired immunodeficiency syndrome	0.000492	0.0126	CcSEcCtD
Dopamine—ADRB1—lung—acquired immunodeficiency syndrome	0.000489	0.00544	CbGeAlD
Dopamine—SLC22A3—lung—acquired immunodeficiency syndrome	0.000486	0.0054	CbGeAlD
Dopamine—Anxiety—Delavirdine—acquired immunodeficiency syndrome	0.000484	0.0124	CcSEcCtD
Dopamine—HTR7—digestive system—acquired immunodeficiency syndrome	0.00048	0.00534	CbGeAlD
Dopamine—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000478	0.0123	CcSEcCtD
Dopamine—SLC6A3—nervous system—acquired immunodeficiency syndrome	0.000478	0.00531	CbGeAlD
Dopamine—MAOB—vagina—acquired immunodeficiency syndrome	0.000475	0.00528	CbGeAlD
Dopamine—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.000475	0.0122	CcSEcCtD
Dopamine—SLC6A4—lung—acquired immunodeficiency syndrome	0.000473	0.00525	CbGeAlD
Dopamine—SLC22A1—nervous system—acquired immunodeficiency syndrome	0.000471	0.00523	CbGeAlD
Dopamine—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000469	0.00521	CbGeAlD
Dopamine—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000466	0.012	CcSEcCtD
Dopamine—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.000466	0.012	CcSEcCtD
Dopamine—HTR1A—spinal cord—acquired immunodeficiency syndrome	0.000461	0.00513	CbGeAlD
Dopamine—SLC6A3—central nervous system—acquired immunodeficiency syndrome	0.00046	0.00511	CbGeAlD
Dopamine—Headache—Didanosine—acquired immunodeficiency syndrome	0.000459	0.0118	CcSEcCtD
Dopamine—MAOA—digestive system—acquired immunodeficiency syndrome	0.000459	0.0051	CbGeAlD
Dopamine—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000459	0.0118	CcSEcCtD
Dopamine—HTR7—blood—acquired immunodeficiency syndrome	0.000458	0.00508	CbGeAlD
Dopamine—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000455	0.0117	CcSEcCtD
Dopamine—DRD1—brain—acquired immunodeficiency syndrome	0.000454	0.00505	CbGeAlD
Dopamine—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000454	0.0117	CcSEcCtD
Dopamine—ADRB1—nervous system—acquired immunodeficiency syndrome	0.000453	0.00504	CbGeAlD
Dopamine—SLC22A1—central nervous system—acquired immunodeficiency syndrome	0.000453	0.00503	CbGeAlD
Dopamine—SLC22A3—nervous system—acquired immunodeficiency syndrome	0.00045	0.005	CbGeAlD
Dopamine—MAOB—lung—acquired immunodeficiency syndrome	0.000449	0.00499	CbGeAlD
Dopamine—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000447	0.0115	CcSEcCtD
Dopamine—CYP2C19—blood—acquired immunodeficiency syndrome	0.000447	0.00496	CbGeAlD
Dopamine—HTR7—spinal cord—acquired immunodeficiency syndrome	0.000441	0.0049	CbGeAlD
Dopamine—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000438	0.0113	CcSEcCtD
Dopamine—SLC6A4—nervous system—acquired immunodeficiency syndrome	0.000438	0.00486	CbGeAlD
Dopamine—MAOA—blood—acquired immunodeficiency syndrome	0.000437	0.00486	CbGeAlD
Dopamine—ADRB1—central nervous system—acquired immunodeficiency syndrome	0.000436	0.00485	CbGeAlD
Dopamine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000436	0.0112	CcSEcCtD
Dopamine—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000434	0.0111	CcSEcCtD
Dopamine—SLC22A3—central nervous system—acquired immunodeficiency syndrome	0.000433	0.00481	CbGeAlD
Dopamine—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000431	0.0111	CcSEcCtD
Dopamine—SLC22A5—digestive system—acquired immunodeficiency syndrome	0.000423	0.0047	CbGeAlD
Dopamine—SLC6A4—central nervous system—acquired immunodeficiency syndrome	0.000421	0.00468	CbGeAlD
Dopamine—MAOA—spinal cord—acquired immunodeficiency syndrome	0.000421	0.00468	CbGeAlD
Dopamine—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.00042	0.0108	CcSEcCtD
Dopamine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000419	0.0108	CcSEcCtD
Dopamine—MAOB—nervous system—acquired immunodeficiency syndrome	0.000416	0.00462	CbGeAlD
Dopamine—SLC6A2—lung—acquired immunodeficiency syndrome	0.000416	0.00462	CbGeAlD
Dopamine—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000415	0.0107	CcSEcCtD
Dopamine—CYP2C19—vagina—acquired immunodeficiency syndrome	0.000414	0.0046	CbGeAlD
Dopamine—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000413	0.0106	CcSEcCtD
Dopamine—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000411	0.0105	CcSEcCtD
Dopamine—COMT—brain—acquired immunodeficiency syndrome	0.000409	0.00454	CbGeAlD
Dopamine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000406	0.0104	CcSEcCtD
Dopamine—MAOA—vagina—acquired immunodeficiency syndrome	0.000405	0.00451	CbGeAlD
Dopamine—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000405	0.0104	CcSEcCtD
Dopamine—SLC22A5—blood—acquired immunodeficiency syndrome	0.000403	0.00448	CbGeAlD
Dopamine—HTR7—lung—acquired immunodeficiency syndrome	0.000401	0.00446	CbGeAlD
Dopamine—MAOB—central nervous system—acquired immunodeficiency syndrome	0.000401	0.00445	CbGeAlD
Dopamine—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.0004	0.0103	CcSEcCtD
Dopamine—Headache—Stavudine—acquired immunodeficiency syndrome	0.000399	0.0102	CcSEcCtD
Dopamine—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000399	0.0102	CcSEcCtD
Dopamine—COMT—lymph node—acquired immunodeficiency syndrome	0.000395	0.00439	CbGeAlD
Dopamine—Headache—Abacavir—acquired immunodeficiency syndrome	0.000393	0.0101	CcSEcCtD
Dopamine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000392	0.0101	CcSEcCtD
Dopamine—HTR1A—nervous system—acquired immunodeficiency syndrome	0.000389	0.00432	CbGeAlD
Dopamine—SLC22A5—spinal cord—acquired immunodeficiency syndrome	0.000388	0.00431	CbGeAlD
Dopamine—SLC6A2—nervous system—acquired immunodeficiency syndrome	0.000385	0.00428	CbGeAlD
Dopamine—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000384	0.00985	CcSEcCtD
Dopamine—MAOA—lung—acquired immunodeficiency syndrome	0.000383	0.00426	CbGeAlD
Dopamine—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.000383	0.00426	CbGeAlD
Dopamine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000379	0.00974	CcSEcCtD
Dopamine—DRD2—lung—acquired immunodeficiency syndrome	0.000379	0.00421	CbGeAlD
Dopamine—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000378	0.00971	CcSEcCtD
Dopamine—HTR1A—central nervous system—acquired immunodeficiency syndrome	0.000374	0.00416	CbGeAlD
Dopamine—SLC22A5—vagina—acquired immunodeficiency syndrome	0.000373	0.00415	CbGeAlD
Dopamine—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000373	0.00957	CcSEcCtD
Dopamine—HTR7—nervous system—acquired immunodeficiency syndrome	0.000371	0.00413	CbGeAlD
Dopamine—SLC6A2—central nervous system—acquired immunodeficiency syndrome	0.000371	0.00412	CbGeAlD
Dopamine—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000369	0.00948	CcSEcCtD
Dopamine—SLC6A3—brain—acquired immunodeficiency syndrome	0.000365	0.00406	CbGeAlD
Dopamine—CYP1A2—blood—acquired immunodeficiency syndrome	0.000365	0.00406	CbGeAlD
Dopamine—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000364	0.00404	CbGeAlD
Dopamine—SLC22A1—brain—acquired immunodeficiency syndrome	0.00036	0.004	CbGeAlD
Dopamine—HTR7—central nervous system—acquired immunodeficiency syndrome	0.000358	0.00397	CbGeAlD
Dopamine—MAOA—nervous system—acquired immunodeficiency syndrome	0.000355	0.00395	CbGeAlD
Dopamine—SLC22A5—lung—acquired immunodeficiency syndrome	0.000353	0.00392	CbGeAlD
Dopamine—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000352	0.00905	CcSEcCtD
Dopamine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000352	0.00904	CcSEcCtD
Dopamine—DRD2—nervous system—acquired immunodeficiency syndrome	0.000351	0.0039	CbGeAlD
Dopamine—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000347	0.00891	CcSEcCtD
Dopamine—CYP2C9—blood—acquired immunodeficiency syndrome	0.000346	0.00385	CbGeAlD
Dopamine—ADRB1—brain—acquired immunodeficiency syndrome	0.000346	0.00385	CbGeAlD
Dopamine—SLC22A3—brain—acquired immunodeficiency syndrome	0.000344	0.00382	CbGeAlD
Dopamine—MAOA—central nervous system—acquired immunodeficiency syndrome	0.000342	0.0038	CbGeAlD
Dopamine—DRD2—central nervous system—acquired immunodeficiency syndrome	0.000338	0.00376	CbGeAlD
Dopamine—SLC6A4—brain—acquired immunodeficiency syndrome	0.000335	0.00372	CbGeAlD
Dopamine—SLC22A3—lymph node—acquired immunodeficiency syndrome	0.000332	0.00369	CbGeAlD
Dopamine—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000329	0.00844	CcSEcCtD
Dopamine—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000327	0.00841	CcSEcCtD
Dopamine—Headache—Indinavir—acquired immunodeficiency syndrome	0.000322	0.00828	CcSEcCtD
Dopamine—CYP1A2—lung—acquired immunodeficiency syndrome	0.00032	0.00355	CbGeAlD
Dopamine—MAOB—brain—acquired immunodeficiency syndrome	0.000318	0.00353	CbGeAlD
Dopamine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000309	0.00794	CcSEcCtD
Dopamine—MAOB—lymph node—acquired immunodeficiency syndrome	0.000307	0.00342	CbGeAlD
Dopamine—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000306	0.00785	CcSEcCtD
Dopamine—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000305	0.00782	CcSEcCtD
Dopamine—HTR1A—brain—acquired immunodeficiency syndrome	0.000297	0.0033	CbGeAlD
Dopamine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000296	0.0076	CcSEcCtD
Dopamine—SLC6A2—brain—acquired immunodeficiency syndrome	0.000295	0.00327	CbGeAlD
Dopamine—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000291	0.00749	CcSEcCtD
Dopamine—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000289	0.00742	CcSEcCtD
Dopamine—SLC6A2—lymph node—acquired immunodeficiency syndrome	0.000285	0.00316	CbGeAlD
Dopamine—HTR7—brain—acquired immunodeficiency syndrome	0.000284	0.00315	CbGeAlD
Dopamine—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000276	0.0071	CcSEcCtD
Dopamine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000274	0.00703	CcSEcCtD
Dopamine—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000273	0.00303	CbGeAlD
Dopamine—MAOA—brain—acquired immunodeficiency syndrome	0.000271	0.00302	CbGeAlD
Dopamine—Headache—Ritonavir—acquired immunodeficiency syndrome	0.00027	0.00692	CcSEcCtD
Dopamine—DRD2—brain—acquired immunodeficiency syndrome	0.000268	0.00298	CbGeAlD
Dopamine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000263	0.00676	CcSEcCtD
Dopamine—MAOA—lymph node—acquired immunodeficiency syndrome	0.000262	0.00291	CbGeAlD
Dopamine—CYP2D6—blood—acquired immunodeficiency syndrome	0.00026	0.00289	CbGeAlD
Dopamine—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000259	0.00666	CcSEcCtD
Dopamine—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000256	0.00656	CcSEcCtD
Dopamine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000251	0.00645	CcSEcCtD
Dopamine—SLC22A5—brain—acquired immunodeficiency syndrome	0.00025	0.00278	CbGeAlD
Dopamine—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000247	0.00636	CcSEcCtD
Dopamine—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000246	0.00632	CcSEcCtD
Dopamine—SLC22A5—lymph node—acquired immunodeficiency syndrome	0.000241	0.00268	CbGeAlD
Dopamine—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000235	0.00603	CcSEcCtD
Dopamine—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000211	0.00234	CbGeAlD
Dopamine—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000203	0.00226	CbGeAlD
Dopamine—CYP2D6—brain—acquired immunodeficiency syndrome	0.000161	0.00179	CbGeAlD
Dopamine—HTR1A—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	3.4e-05	0.00104	CbGpPWpGaD
Dopamine—DRD5—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	3.36e-05	0.00103	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	3.33e-05	0.00102	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	3.33e-05	0.00102	CbGpPWpGaD
Dopamine—DRD5—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	3.31e-05	0.00102	CbGpPWpGaD
Dopamine—SLC22A2—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	3.3e-05	0.00102	CbGpPWpGaD
Dopamine—HTR7—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	3.29e-05	0.00101	CbGpPWpGaD
Dopamine—DRD4—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	3.26e-05	0.001	CbGpPWpGaD
Dopamine—DRD4—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	3.26e-05	0.001	CbGpPWpGaD
Dopamine—ADRB1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	3.2e-05	0.000984	CbGpPWpGaD
Dopamine—DBH—Metabolism—ALB—acquired immunodeficiency syndrome	3.17e-05	0.000973	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	3.15e-05	0.000968	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	3.14e-05	0.000967	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	3.13e-05	0.000964	CbGpPWpGaD
Dopamine—DRD1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	3.12e-05	0.00096	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	3.09e-05	0.000951	CbGpPWpGaD
Dopamine—HTR7—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	3.09e-05	0.000951	CbGpPWpGaD
Dopamine—HTR7—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	3.09e-05	0.000951	CbGpPWpGaD
Dopamine—SLC22A1—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	3.08e-05	0.000947	CbGpPWpGaD
Dopamine—DRD3—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	3.08e-05	0.000947	CbGpPWpGaD
Dopamine—HTR1A—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	3.06e-05	0.000941	CbGpPWpGaD
Dopamine—DRD5—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	3.05e-05	0.000938	CbGpPWpGaD
Dopamine—DRD5—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	3.03e-05	0.000931	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	3.01e-05	0.000926	CbGpPWpGaD
Dopamine—DRD5—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	3.01e-05	0.000924	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	3e-05	0.000921	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	3e-05	0.000921	CbGpPWpGaD
Dopamine—DRD2—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	2.98e-05	0.000917	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	2.96e-05	0.00091	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	2.96e-05	0.00091	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	2.96e-05	0.000909	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	2.96e-05	0.000909	CbGpPWpGaD
Dopamine—HTR1A—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	2.95e-05	0.000908	CbGpPWpGaD
Dopamine—DRD1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	2.93e-05	0.000902	CbGpPWpGaD
Dopamine—DRD1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	2.93e-05	0.000902	CbGpPWpGaD
Dopamine—DRD3—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	2.9e-05	0.00089	CbGpPWpGaD
Dopamine—DRD3—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	2.9e-05	0.00089	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	2.83e-05	0.000871	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	2.82e-05	0.000866	CbGpPWpGaD
Dopamine—ADRB1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	2.81e-05	0.000863	CbGpPWpGaD
Dopamine—MAOA—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	2.8e-05	0.000862	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	2.8e-05	0.00086	CbGpPWpGaD
Dopamine—SLC6A4—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	2.79e-05	0.000858	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.79e-05	0.000857	CbGpPWpGaD
Dopamine—DRD5—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.75e-05	0.000845	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	2.71e-05	0.000833	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	2.69e-05	0.000829	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	2.69e-05	0.000828	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	2.69e-05	0.000828	CbGpPWpGaD
Dopamine—DRD2—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	2.69e-05	0.000826	CbGpPWpGaD
Dopamine—HTR1A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	2.68e-05	0.000825	CbGpPWpGaD
Dopamine—SLC22A3—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	2.68e-05	0.000823	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	2.67e-05	0.000822	CbGpPWpGaD
Dopamine—SLC22A5—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	2.67e-05	0.000821	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	2.66e-05	0.000819	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	2.66e-05	0.000819	CbGpPWpGaD
Dopamine—ADRB1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	2.64e-05	0.000811	CbGpPWpGaD
Dopamine—ADRB1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	2.64e-05	0.000811	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	2.63e-05	0.000808	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	2.63e-05	0.000808	CbGpPWpGaD
Dopamine—HTR7—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	2.62e-05	0.000807	CbGpPWpGaD
Dopamine—HTR7—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.59e-05	0.000796	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	2.58e-05	0.000792	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	2.58e-05	0.000792	CbGpPWpGaD
Dopamine—HTR7—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.55e-05	0.000785	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	2.55e-05	0.000783	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—TAT—acquired immunodeficiency syndrome	2.52e-05	0.000776	CbGpPWpGaD
Dopamine—HTR1A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	2.52e-05	0.000776	CbGpPWpGaD
Dopamine—HTR1A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	2.52e-05	0.000776	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.52e-05	0.000775	CbGpPWpGaD
Dopamine—DRD4—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	2.51e-05	0.000773	CbGpPWpGaD
Dopamine—DRD4—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.48e-05	0.000762	CbGpPWpGaD
Dopamine—DRD4—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.44e-05	0.000751	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	2.44e-05	0.000749	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	2.44e-05	0.000749	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	2.4e-05	0.000737	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	2.4e-05	0.000737	CbGpPWpGaD
Dopamine—HTR1A—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	2.38e-05	0.000733	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.37e-05	0.000728	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.37e-05	0.000728	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	2.37e-05	0.000728	CbGpPWpGaD
Dopamine—DRD2—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	2.36e-05	0.000725	CbGpPWpGaD
Dopamine—HTR7—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.35e-05	0.000723	CbGpPWpGaD
Dopamine—HTR7—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.33e-05	0.000718	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	2.33e-05	0.000717	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—TAT—acquired immunodeficiency syndrome	2.32e-05	0.000714	CbGpPWpGaD
Dopamine—HTR7—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.32e-05	0.000712	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—TAT—acquired immunodeficiency syndrome	2.3e-05	0.000708	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	2.29e-05	0.000705	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	2.29e-05	0.000705	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	2.26e-05	0.000696	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	2.26e-05	0.000696	CbGpPWpGaD
Dopamine—DRD1—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	2.26e-05	0.000696	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.25e-05	0.000692	CbGpPWpGaD
Dopamine—DRD4—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.23e-05	0.000687	CbGpPWpGaD
Dopamine—DRD1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.23e-05	0.000686	CbGpPWpGaD
Dopamine—DRD3—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	2.23e-05	0.000686	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.22e-05	0.000682	CbGpPWpGaD
Dopamine—DRD2—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	2.22e-05	0.000681	CbGpPWpGaD
Dopamine—DRD2—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	2.22e-05	0.000681	CbGpPWpGaD
Dopamine—DRD3—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.2e-05	0.000677	CbGpPWpGaD
Dopamine—DRD1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.2e-05	0.000676	CbGpPWpGaD
Dopamine—DRD3—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.17e-05	0.000667	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.15e-05	0.000661	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—AGPS—acquired immunodeficiency syndrome	2.15e-05	0.00066	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	2.14e-05	0.000658	CbGpPWpGaD
Dopamine—HTR7—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.12e-05	0.000652	CbGpPWpGaD
Dopamine—SLC6A2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	2.08e-05	0.000641	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.06e-05	0.000632	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	2.05e-05	0.000629	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.03e-05	0.000624	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.03e-05	0.000623	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	2.01e-05	0.000619	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	2.01e-05	0.000619	CbGpPWpGaD
Dopamine—DRD1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.01e-05	0.000618	CbGpPWpGaD
Dopamine—ADRB1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.01e-05	0.000617	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2e-05	0.000615	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2e-05	0.000614	CbGpPWpGaD
Dopamine—DRD3—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.98e-05	0.00061	CbGpPWpGaD
Dopamine—ADRB1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.98e-05	0.000608	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—AGPS—acquired immunodeficiency syndrome	1.97e-05	0.000607	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.97e-05	0.000606	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—TAT—acquired immunodeficiency syndrome	1.97e-05	0.000605	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—AGPS—acquired immunodeficiency syndrome	1.96e-05	0.000602	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.94e-05	0.000597	CbGpPWpGaD
Dopamine—HTR1A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.92e-05	0.00059	CbGpPWpGaD
Dopamine—HTR1A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.89e-05	0.000581	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.86e-05	0.000572	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.85e-05	0.000569	CbGpPWpGaD
Dopamine—SLC6A3—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.85e-05	0.000567	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.83e-05	0.000562	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.83e-05	0.000562	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.83e-05	0.000562	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.83e-05	0.000562	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.82e-05	0.00056	CbGpPWpGaD
Dopamine—ADRB1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.81e-05	0.000556	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.8e-05	0.000554	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.8e-05	0.000554	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.8e-05	0.000552	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.78e-05	0.000546	CbGpPWpGaD
Dopamine—DRD5—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.75e-05	0.000538	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.75e-05	0.000538	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.75e-05	0.000538	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.74e-05	0.000536	CbGpPWpGaD
Dopamine—HTR1A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.73e-05	0.000532	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.72e-05	0.000528	CbGpPWpGaD
Dopamine—DRD2—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	1.71e-05	0.000525	CbGpPWpGaD
Dopamine—DRD2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.69e-05	0.000518	CbGpPWpGaD
Dopamine—SLC22A2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.68e-05	0.000516	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.67e-05	0.000515	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—AGPS—acquired immunodeficiency syndrome	1.67e-05	0.000514	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.66e-05	0.000512	CbGpPWpGaD
Dopamine—DRD2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.66e-05	0.00051	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.65e-05	0.000508	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.64e-05	0.000505	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.62e-05	0.000499	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.59e-05	0.000489	CbGpPWpGaD
Dopamine—DRD5—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.59e-05	0.000488	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.57e-05	0.000484	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.57e-05	0.000484	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.57e-05	0.000483	CbGpPWpGaD
Dopamine—SLC22A1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.57e-05	0.000481	CbGpPWpGaD
Dopamine—COMT—Metabolism—ALB—acquired immunodeficiency syndrome	1.56e-05	0.000481	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.55e-05	0.000478	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.55e-05	0.000478	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.53e-05	0.000471	CbGpPWpGaD
Dopamine—DRD2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.52e-05	0.000467	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.51e-05	0.000464	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.51e-05	0.000463	CbGpPWpGaD
Dopamine—MAOB—Metabolism—ALB—acquired immunodeficiency syndrome	1.48e-05	0.000456	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.44e-05	0.000443	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.42e-05	0.000435	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.42e-05	0.000435	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.4e-05	0.00043	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.39e-05	0.000427	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.38e-05	0.000424	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.37e-05	0.000421	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.35e-05	0.000416	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.35e-05	0.000416	CbGpPWpGaD
Dopamine—HTR7—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.35e-05	0.000415	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.33e-05	0.000409	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.31e-05	0.000403	CbGpPWpGaD
Dopamine—DRD4—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.29e-05	0.000397	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.26e-05	0.000389	CbGpPWpGaD
Dopamine—SLC22A3—Metabolism—ALB—acquired immunodeficiency syndrome	1.25e-05	0.000386	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.25e-05	0.000385	CbGpPWpGaD
Dopamine—HTR7—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.22e-05	0.000377	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.2e-05	0.000368	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.2e-05	0.000368	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.19e-05	0.000365	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.19e-05	0.000365	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.18e-05	0.000363	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.18e-05	0.000363	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.17e-05	0.00036	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.16e-05	0.000358	CbGpPWpGaD
Dopamine—DRD1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.16e-05	0.000357	CbGpPWpGaD
Dopamine—DRD3—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.15e-05	0.000353	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.08e-05	0.000332	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.08e-05	0.000331	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.06e-05	0.000327	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.06e-05	0.000326	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.06e-05	0.000324	CbGpPWpGaD
Dopamine—ADRB1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.04e-05	0.000321	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.04e-05	0.00032	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.03e-05	0.000317	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.01e-05	0.000312	CbGpPWpGaD
Dopamine—HTR1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	9.99e-06	0.000307	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	9.88e-06	0.000304	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	9.7e-06	0.000298	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	9.49e-06	0.000292	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—IL2—acquired immunodeficiency syndrome	9.38e-06	0.000288	CbGpPWpGaD
Dopamine—DRD5—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	9.34e-06	0.000287	CbGpPWpGaD
Dopamine—MAOA—Metabolism—ALB—acquired immunodeficiency syndrome	9.3e-06	0.000286	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	9.28e-06	0.000285	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	9.07e-06	0.000279	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.04e-06	0.000278	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	9.01e-06	0.000277	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	8.91e-06	0.000274	CbGpPWpGaD
Dopamine—DRD2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	8.77e-06	0.00027	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.15e-06	0.00025	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	7.97e-06	0.000245	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—ALB—acquired immunodeficiency syndrome	7.87e-06	0.000242	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	7.7e-06	0.000237	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—ALB—acquired immunodeficiency syndrome	7.33e-06	0.000225	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.23e-06	0.000222	CbGpPWpGaD
Dopamine—HTR7—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.2e-06	0.000221	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.92e-06	0.000213	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.89e-06	0.000212	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.23e-06	0.000192	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.2e-06	0.000191	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.15e-06	0.000189	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.12e-06	0.000188	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.6e-06	0.000172	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.58e-06	0.000171	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.51e-06	0.00017	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.36e-06	0.000165	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.33e-06	0.000164	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.71e-06	0.000145	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.68e-06	0.000144	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—ALB—acquired immunodeficiency syndrome	4.4e-06	0.000135	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.25e-06	0.000131	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.07e-06	0.000125	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—ALB—acquired immunodeficiency syndrome	4.05e-06	0.000124	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—ALB—acquired immunodeficiency syndrome	4.01e-06	0.000123	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.66e-06	0.000113	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.62e-06	0.000111	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—ALB—acquired immunodeficiency syndrome	3.43e-06	0.000105	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.29e-06	0.000101	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.15e-06	9.69e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.77e-06	8.51e-05	CbGpPWpGaD
